A 27-year-old woman comes to the clinic reporting a 4-month history of rapidly increasing facial and body hair. She also mentions that her voice has deepened recently and her menstrual periods, previously regular, have stopped completely over the same timeframe. She has no significant past medical history and takes no medications. Her blood pressure is 118/76 mm Hg, pulse is 72/min, and BMI is 23 kg/m². Physical examination reveals coarse, dark hair over the upper lip, chin, chest, and lower abdomen. Temporal hair thinning is noted. Pelvic examination demonstrates significant clitoromegaly. Which of the following is the most appropriate next step in the evaluation of this patient?
- Measurement of serum testosterone and dehydroepiandrosterone sulfateCevap
- BInitiation of an oral contraceptive pill and spironolactone
- CMeasurement of serum 17-hydroxyprogesterone
- DPelvic ultrasonography and abdominal computed tomography
- EMeasurement of serum luteinizing hormone and follicle-stimulating hormone
Cevap
Measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS) is the most appropriate initial diagnostic step.
The correct answer is measurement of serum testosterone and dehydroepiandrosterone sulfate (DHEAS). This patient exhibits clear signs of severe virilization, including clitoromegaly, a deepening voice, and temporal hair thinning. Crucially, the onset of these symptoms has been rapid, developing over just 4 months. While polycystic ovary syndrome (PCOS) is the most common cause of hyperandrogenism in women, it typically presents peripubertally with a gradual onset of mild to moderate hirsutism and acne. Rapid, severe virilization is the classic presentation of a malignant or benign androgen-secreting tumor (either ovarian or adrenal). The appropriate initial step in evaluation is to measure biochemical markers to confirm hyperandrogenemia and localize the source. Very high testosterone levels (>150 ng/dL) point toward an ovarian source (e.g., Sertoli-Leydig cell tumor), whereas markedly elevated DHEAS levels (>700 mcg/dL) point toward an adrenal source (e.g., adrenocortical carcinoma). Once the biochemical source is established, targeted anatomical imaging (ultrasound for ovaries, CT for adrenal glands) can be performed.
Adım Adım Çözüm
Anahtar Kavram
Patients presenting with rapid onset of severe hyperandrogenism and virilization (e.g., clitoromegaly, voice deepening) require immediate biochemical evaluation with serum testosterone and DHEAS levels to identify and localize a suspected androgen-secreting tumor.